View publication

↩ Back to all publications
Publication
PropertyValue
Working Groups Lingor
SubprojectNone
Open AccessOpen Access Yes
Publication TypeJournal Article
Peer ReviewedYes
PMIDPubMed ID 39424560
DOIDOI 10.1016/S1474-4422(24)00373-9
Publication Year2024
TitleSafety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial.
JournalThe Lancet. Neurology
ISSN1474-4422
ESSN1474-4465
URL https://www.ncbi.nlm.nih.gov/pubmed/?term=39424560%5Buid%5D
Pages1133-1146
Issue11
Volume23
Journal AbbreviationLancet Neurol
AuthorsKoch JC, Leha A, Bidner H, Cordts I, Dorst J, Günther R, Zeller D, Braun N, Metelmann M, Corcia P, De La Cruz E, Weydt P, Meyer T, Großkreutz J, Soriani MH, Attarian S, Weishaupt JH, Weyen U, Kuttler J, Zurek G, Rogers ML, Feneberg E, Deschauer M, Neuwirth C, Wuu J, Ludolph AC, Schmidt J, Remane Y, Camu W, Friede T, Benatar M, Weber M, Lingor P
First AuthorKoch JC
Last AuthorLingor P